PUBLISHER: The Business Research Company | PRODUCT CODE: 1658773
PUBLISHER: The Business Research Company | PRODUCT CODE: 1658773
Aminoglycosides Global Market Report 2025
Aminoglycosides, a class of antibiotics renowned for their ability to impede protein synthesis, play a crucial role in treating infections caused by aerobic gram-negative bacilli. These infections commonly manifest in the abdomen and urinary tract, as well as in cases of bacteremia and endocarditis.
Among the primary products in the aminoglycoside category are neomycin, tobramycin, gentamicin, amikacin, paromomycin, streptomycin, kanamycin, and others. Neomycin, for instance, is specifically employed to prevent bacterial infections in the intestines. Derived from the metabolic products of Streptomyces fradiae, neomycin is recognized as a broad-spectrum aminoglycoside antibiotic. Aminoglycosides are administered through various routes, including injectables (parenteral), feed, intra-mammary, topical, and oral applications. Their use extends across veterinary medicine, addressing conditions such as skin infections, respiratory diseases, urinary tract infections, pelvic diseases, and various other ailments.
The aminoglycosides market research report is one of a series of new reports from The Business Research Company that provides aminoglycosides market statistics, including aminoglycosides industry global market size, regional shares, competitors with an aminoglycosides market share, detailed aminoglycosides market segments, market trends and opportunities, and any further data you may need to thrive in the aminoglycosides industry. This aminoglycosides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The aminoglycosides market size has grown steadily in recent years. It will grow from $1.84 billion in 2024 to $1.93 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to antibiotic discovery and development, advancements in medicinal chemistry, clinical effectiveness in treating gram-negative infections, broad-spectrum antibacterial activity, hospital-acquired infection control, global population growth, post-surgery infection prevention, research and development investments.
The aminoglycosides market size is expected to see strong growth in the next few years. It will grow to $2.46 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to advancements in antibiotic stewardship, personalized medicine approaches, innovations in drug delivery, global spread of antibiotic-resistant strains, increasing focus on rare diseases, expanding applications in dermatology, patient education on antibiotic use. Major trends in the forecast period include biotechnological innovations, combination therapies, technological advancements in production, price competition.
The aminoglycosides market is anticipated to witness growth due to the escalating incidences of animal disease outbreaks. These outbreaks significantly impact the normal functions of animals and create a demand for aminoglycosides, like amikacin and gentamicin, widely used in veterinary medicine. A recent example is the anthrax outbreak reported and monitored in remote areas of Canada's Wood Buffalo National Park in July 2022. This trend is expected to continue, further boosting the demand for aminoglycosides within the market.
The growing ownership of pets is poised to fuel the expansion of the aminoglycosides market. The increased number of pet owners, who are responsible for the care and well-being of animals kept as companions, contributes to the market's growth by expanding the customer base. This surge in pet ownership encourages preventive healthcare practices for pets and drives investments in veterinary pharmaceuticals, including aminoglycosides, to address various health needs. An example of this growth is evident in the UK, where approximately 57% of households, totaling 16.2 million, have 38 million pets, as reported by Improve International in March 2023. This rise in pet ownership remains a driving force behind the growth of the aminoglycosides market.
Process innovation is a significant trend in the aminoglycosides market, with major companies focusing on new process solutions to enhance their competitive position. For example, in February 2024, Cipla Limited, an India-based pharmaceutical company, received approval from the Central Drugs Standard Control Organization (CDSCO) for ZEMDRI (plazomicin), an intravenous aminoglycoside antibiotic. This antibiotic is specifically indicated for treating complicated urinary tract infections (cUTIs), including pyelonephritis.
Major companies in the aminoglycosides market are concentrating on developing innovative products, including active ingredients that are effective against specific bacterial pathogens. An active ingredient is the chemical component within a product, such as a drug or pesticide, that produces the desired therapeutic or biological effect. For example, in July 2023, Bimeda US, a U.S.-based animal health company, launched SpectoGard, an injectable solution designed to treat various bacterial infections in cattle. This product contains spectinomycin sulfate, an antibiotic used for treating bovine respiratory disease (BRD) caused by particular bacterial pathogens. The solution offers veterinarians and cattle producers in the U.S. a convenient treatment option to enhance herd health. Its FDA status underscores its safety and efficacy for livestock use.
In April 2022, Animal Dermatology Group Inc., a US-based veterinary company, executed the acquisition of Austin Veterinary Dermatology & Allergy. The strategic acquisition, completed for an undisclosed amount, is part of Animal Dermatology Group's ongoing efforts to expand its geographic presence and consolidate its market position. Through this acquisition, the company aims to broaden its scope and offer top-tier treatment for skin diseases across more regions. This move reinforces Animal Dermatology Group's commitment to enhancing its expertise in veterinary dermatology. Austin Veterinary Dermatology & Allergy, a US-based biotechnology company, aligns well with the expansion goals of Animal Dermatology Group.
Major companies operating in the aminoglycosides market are Kremoint Pharma Pvt. Ltd., Vega Pharma Ltd., Jiangxi Bolai Pharmacy Co. Ltd., Xian Wison Biological Technology Co. Ltd., Hangzhou Uniwise International Co. Ltd., HuvePharma Inc., Yi Chang Veterinary Medicine Factory, Medson Pharmaceuticals, Medico Remedies Pvt. Ltd., Cipla Limited, Pfizer Inc., Allergan PLC, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Novartis AG, Johnson & Johnson Inc., Bristol Myers Squibb Company, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifescience limited, Lupin Limited, Aurobindo Pharma Limited, Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Mylan N.V., Sanofi SA, Wyeth Pharmaceuticals Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., GlaxoSmithKline plc
Asia-Pacific was the largest region in the aminoglycosides market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the aminoglycosides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the aminoglycosides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The aminoglycosides market consists of sales of plazomicin and netilmicin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Aminoglycosides Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on aminoglycosides market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for aminoglycosides ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aminoglycosides market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Neomycin; Tobramycin; Gentamicin; Amikacin; Paromomycin; Streptomycin; Kanamycin; Other Products
- 2) By Route Of Administration: Injectables (Parenteral); Feed; Intra-Mammary; Topical; Oral
- 3) By Application: Veterinary; Skin Infection; Respiratory Diseases; UTI And Pelvic Diseases; Other Diseases
- Subsegments:
- 1) By Neomycin: Topical Formulations; Oral Formulations
- 2) By Tobramycin: Inhalation Solutions; Injectable Formulations; Ophthalmic Solutions
- 3) By Gentamicin: Injectable Formulations; Topical Formulations; Ophthalmic Solutions
- 4) By Amikacin: Injectable Formulations; Inhalation Solutions
- 5) By Paromomycin: Oral Formulations; Injectable Formulations
- 6) By Streptomycin: Injectable Formulations; Combination Therapies
- 7) By Kanamycin: Injectable Formulations; Oral Formulations
- 8) By Other Products: Combinations Of Aminoglycosides; Novel Aminoglycoside Derivatives
- Companies Mentioned: Kremoint Pharma Pvt. Ltd.; Vega Pharma Ltd.; Jiangxi Bolai Pharmacy Co. Ltd.; Xian Wison Biological Technology Co. Ltd.; Hangzhou Uniwise International Co. Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Aminoglycosides Market Characteristics
3. Aminoglycosides Market Trends And Strategies
4. Aminoglycosides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Aminoglycosides Growth Analysis And Strategic Analysis Framework
- 5.1. Global Aminoglycosides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Aminoglycosides Market Growth Rate Analysis
- 5.4. Global Aminoglycosides Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Aminoglycosides Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Aminoglycosides Total Addressable Market (TAM)
6. Aminoglycosides Market Segmentation
- 6.1. Global Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neomycin
- Tobramycin
- Gentamicin
- Amikacin
- Paromomycin
- Streptomycin
- Kanamycin
- Other Products
- 6.2. Global Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Injectables (Parenteral)
- Feed
- Intra-Mammary
- Topical
- Oral
- 6.3. Global Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Veterinary
- Skin Infection
- Respiratory Diseases
- UTI And Pelvic Diseases
- Other Diseases
- 6.4. Global Aminoglycosides Market, Sub-Segmentation Of Neomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Formulations
- Oral Formulations
- 6.5. Global Aminoglycosides Market, Sub-Segmentation Of Tobramycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inhalation Solutions
- Injectable Formulations
- Ophthalmic Solutions
- 6.6. Global Aminoglycosides Market, Sub-Segmentation Of Gentamicin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Injectable Formulations
- Topical Formulations
- Ophthalmic Solutions
- 6.7. Global Aminoglycosides Market, Sub-Segmentation Of Amikacin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Injectable Formulations
- Inhalation Solutions
- 6.8. Global Aminoglycosides Market, Sub-Segmentation Of Paromomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Formulations
- Injectable Formulations
- 6.9. Global Aminoglycosides Market, Sub-Segmentation Of Streptomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Injectable Formulations
- Combination Therapies
- 6.10. Global Aminoglycosides Market, Sub-Segmentation Of Kanamycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Injectable Formulations
- Oral Formulations
- 6.11. Global Aminoglycosides Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Combinations Of Aminoglycosides
- Novel Aminoglycoside Derivatives
7. Aminoglycosides Market Regional And Country Analysis
- 7.1. Global Aminoglycosides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Aminoglycosides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Aminoglycosides Market
- 8.1. Asia-Pacific Aminoglycosides Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Aminoglycosides Market
- 9.1. China Aminoglycosides Market Overview
- 9.2. China Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Aminoglycosides Market
- 10.1. India Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Aminoglycosides Market
- 11.1. Japan Aminoglycosides Market Overview
- 11.2. Japan Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Aminoglycosides Market
- 12.1. Australia Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Aminoglycosides Market
- 13.1. Indonesia Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Aminoglycosides Market
- 14.1. South Korea Aminoglycosides Market Overview
- 14.2. South Korea Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Aminoglycosides Market
- 15.1. Western Europe Aminoglycosides Market Overview
- 15.2. Western Europe Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Aminoglycosides Market
- 16.1. UK Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Aminoglycosides Market
- 17.1. Germany Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Aminoglycosides Market
- 18.1. France Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Aminoglycosides Market
- 19.1. Italy Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Aminoglycosides Market
- 20.1. Spain Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Aminoglycosides Market
- 21.1. Eastern Europe Aminoglycosides Market Overview
- 21.2. Eastern Europe Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Aminoglycosides Market
- 22.1. Russia Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Aminoglycosides Market
- 23.1. North America Aminoglycosides Market Overview
- 23.2. North America Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Aminoglycosides Market
- 24.1. USA Aminoglycosides Market Overview
- 24.2. USA Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Aminoglycosides Market
- 25.1. Canada Aminoglycosides Market Overview
- 25.2. Canada Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Aminoglycosides Market
- 26.1. South America Aminoglycosides Market Overview
- 26.2. South America Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Aminoglycosides Market
- 27.1. Brazil Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Aminoglycosides Market
- 28.1. Middle East Aminoglycosides Market Overview
- 28.2. Middle East Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Aminoglycosides Market
- 29.1. Africa Aminoglycosides Market Overview
- 29.2. Africa Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Aminoglycosides Market Competitive Landscape And Company Profiles
- 30.1. Aminoglycosides Market Competitive Landscape
- 30.2. Aminoglycosides Market Company Profiles
- 30.2.1. Kremoint Pharma Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Vega Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Jiangxi Bolai Pharmacy Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Xian Wison Biological Technology Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Hangzhou Uniwise International Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Aminoglycosides Market Other Major And Innovative Companies
- 31.1. HuvePharma Inc.
- 31.2. Yi Chang Veterinary Medicine Factory
- 31.3. Medson Pharmaceuticals
- 31.4. Medico Remedies Pvt. Ltd.
- 31.5. Cipla Limited
- 31.6. Pfizer Inc.
- 31.7. Allergan PLC
- 31.8. Teva Pharmaceutical Industries Ltd.
- 31.9. Zoetis Inc.
- 31.10. Novartis AG
- 31.11. Johnson & Johnson Inc.
- 31.12. Bristol Myers Squibb Company
- 31.13. Sandoz International GmbH
- 31.14. Sun Pharmaceutical Industries Ltd.
- 31.15. Zydus Lifescience limited
32. Global Aminoglycosides Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Aminoglycosides Market
34. Recent Developments In The Aminoglycosides Market
35. Aminoglycosides Market High Potential Countries, Segments and Strategies
- 35.1 Aminoglycosides Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Aminoglycosides Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Aminoglycosides Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
